Market Overview:
Recombinant erythropoietin or Epoetin alfa is a biosimilar drug used for the treatment of anemia. It stimulates the production of red blood cells and helps increasing hemoglobin levels in chronic kidney disease and cancer patients undergoing chemotherapy.
Market key trends:
One of the key trends in the recombinant erythropoietin market is increasing adoption of telemedicine. The COVID-19 pandemic has accelerated the utilization of telemedicine ... Read more
